Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PSMC1P3 (proteasome 26S subunit, ATPase 1 pseudogene 3) is a pseudogene that resembles the gene encoding an ATPase subunit of the 26S proteasome but does not produce a functional protein, nor is it part of the canonical proteasome complex[1][7]. It is listed as ENSG00000231244 in Ensembl and does not have known biological or disease-associated roles. Functional protein-coding genes from the 26S proteasome ATPase subunit family, such as PSMC1 and PSMC3, participate in ATP-dependent ubiquitin-mediated protein degradation, but PSMC1P3 itself does not encode a receptor, enzyme, transporter, or any other canonical drug target class[1][7]. Essential context and supporting details: - PSMC1P3 is explicitly labeled a "pseudogene" in genomic databases, meaning it is a non-functional remnant of a gene that arose through gene duplication or retrotransposition, and it does not produce an active protein[1][7]. - There is no evidence from genetic, proteomic, or pharmacological resources that PSMC1P3 has any functional role in cellular processes, nor is it targeted by any known therapies[1][7]. - It should not be confused with PSMC1 or other 26S proteasome ATPase subunit genes, which do encode functional proteins involved in protein degradation and cellular homeostasis[8][2][4]. If you intended to refer to a functional proteasome ATPase subunit (such as PSMC1 or PSMC3), those proteins have significant biological and therapeutic relevance but are distinct from PSMC1P3.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Proteasome 26S subunit, ATPase 1 pseudogene 3 (PSMC1P3).